LOGIN

International Epidemiology Databases to Evaluate AIDS

Home >> Publications >> Tobacco use and its determinants in HIV-infected patients on antiretroviral therapy in West African countries.

Publication

Author(s):

Jaquet A, Ekouevi DK, Aboubakrine M, Bashi J, Messou E, Maiga M, Traore HA, Zannou M, Guehi C, Ba-Gomis FO, Minga A, Allou G, Eholie SP, Dabis F, Bissagnene E, Sasco AJ.

Pub Title:

Tobacco use and its determinants in HIV-infected patients on antiretroviral therapy in West African countries.

Pub Date:

Nov 30 2009

Pub Region(s):

West Africa

Journal Issue:

13

Page Number:
1433-9

Journal:

Title: 
International Journal of Tuberculosis and Lung Disease
Link: 
http://www.ingentaconnect.com/content/iuatld/ijtld/2009/00000013/00000011/art00021?token=00531fa2ba56bc63be10cf7573d257025702c23442f7a407b765e205f7c4e75477e4324576b6427384e

PubMed: 19861019
Pub PDF:

Abstract
BACKGROUND
: Tobacco smoking is common in human immunodeficiency virus (HIV) infected patients from industrialised countries. In West Africa, few data concerning tobacco consumption exist.

METHODS: A cross-sectional survey of the International Epidemiological Database to Evaluate AIDS (IeDEA) network in West Africa was conducted. Health workers administered a questionnaire assessing tobacco and cannabis consumption among patients receiving antiretroviral treatment. Regular smokers were defined as current smokers who smoked >1 cigarette per day for >or=1 year.

RESULTS: Overall, 2920 patients were enrolled in three countries. The prevalence of ever smokers and regular smokers were respectively 46.2% (95%CI 42.8-49.5) and 15.6% (95%CI 13.2-18.0) in men and 3.7% (95%CI 2.9-4.5) and 0.6% (95%CI 0.3-0.9) in women. Regular smoking was associated with being from Côte d'Ivoire or Mali compared to Benin (OR 4.6, 95%CI 2.9-7.3 and 7.7, 95%CI 4.4-13.6), severely impaired immunological status at highly active antiretroviral treatment initiation (OR 1.5, 95%CI 1.1-2.2) and history of tuberculosis (TB; OR 1.8, 95%CI 1.1-3.0).

CONCLUSION: There are marked differences in smoking prevalence among these West African countries. This survey approach also provides proof of the association between cigarette smoking and TB in HIV-infected patients, a major public health issue in this part of the world.

PMID: 19861019 [PubMed - indexed for MEDLINE]

PMCID: PMC2884027

 

The following websites provide guidelines and policies when citing from PubMed®: http://www.ncbi.nlm.nih.gov/books/NBK7243/
http://www.nlm.nih.gov/bsd/policy/cit_format.html

Citation:

Jaquet A, Ekouevi DK, Aboubakrine M, Bashi J, Messou E, Maiga M, Traore HA, Zannou M, Guehi C, Ba-Gomis FO, Minga A, Allou G, Eholie SP, Dabis F, Bissagnene E, Sasco AJ. Tobacco use and its determinants in HIV-infected patients on antiretroviral therapy in West African countries. Int J Tuberc Lung Dis. 2009 Nov;13(11):1433-9. PubMed PMID: 19861019; PubMed Central PMCID: PMC2884027.